Viral and Nonviral Transfer of Genetic Materials to Adipose Tissues: Toward a Gold Standard Approach.

Diabetes
Steven M Romanelli, Ormond A MacDougald

Abstract

Gene transfer using viral or nonviral vectors enables the ability to manipulate specific cells and tissues for gene silencing, protein overexpression, or genome modification. Despite the widespread application of viral- and non-viral-mediated gene transfer to liver, heart, skeletal muscle, and the central nervous system, its use in adipose tissue has been limited. This is largely because adipose tissue is distributed throughout the body in distinct depots and adipocytes make up a minority of the cells within the tissue, making transduction difficult. Currently, there is no consensus methodology for efficient gene transfer to adipose tissue and many studies report conflicting information with regard to transduction efficiency and vector biodistribution. In this review, we summarize the challenges associated with gene transfer to adipose tissue and report on innovations that improve efficacy. We describe how vector and route of administration are the two key factors that influence transduction efficiency and outline a "gold standard" approach and experimental workflow for validating gene transfer to adipose tissue. Lastly, we speculate on how CRISPR/Cas9 can be integrated to improve adipose tissue research.

References

May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y YangJ M Wilson
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·P MuzzinS L Woo
Feb 8, 2003·DNA and Cell Biology·Ricardo Quinonez, Richard E Sutton
Jan 13, 2004·Physiological Reviews·Barbara Cannon, Jan Nedergaard
May 11, 2004·Nature Medicine·Mikhail G KoloninWadih Arap
Jul 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Lili YangPin Wang
Sep 18, 2007·Genesis : the Journal of Genetics and Development·Mandar Deepak MuzumdarLiqun Luo
Apr 17, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Carmela ZincarelliJoseph E Rabinowitz
Jul 7, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·R YangS A Qureshi
Mar 2, 2011·Cell Metabolism·Jun EguchiEvan D Rosen
Apr 19, 2011·Nature Reviews. Genetics·Federico Mingozzi, Katherine A High
Sep 18, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Md Nazir HossenHideyoshi Harashima
Nov 30, 2012·Molecular Endocrinology·Shannon E MullicanMitchell A Lazar
Dec 5, 2012·Advanced Biomedical Research·Nouri NayerossadatPalizban Abas Ali
Jan 17, 2013·Diabetes·Kevin Y LeeC Ronald Kahn
May 29, 2013·Trends in Endocrinology and Metabolism : TEM·Kanta ChechiDenis Richard
Nov 28, 2013·Current Gene Therapy·William S M Wold, Karoly Toth
Feb 1, 2014·Methods in Enzymology·Sebastian D ParleeOrmond A MacDougald
Apr 11, 2014·Adipocyte·Qiong A Wang, Philipp E Scherer
May 17, 2014·Gene Therapy·S M O'NeillM P Reilly
Jul 6, 2014·Cell·James C LoBruce M Spiegelman
Jul 30, 2014·Adipocyte·Elise JefferyMatthew S Rodeheffer
Aug 1, 2014·Science Translational Medicine·Siegfried UssarC Ronald Kahn
Sep 30, 2014·Cell·Randall J PlattFeng Zhang
Oct 6, 2014·Nature Materials·Young-Wook WonYong-Hee Kim
Oct 20, 2014·Nature Biotechnology·Lukasz SwiechFeng Zhang
Nov 11, 2014·Molecular Therapy. Methods & Clinical Development·Xianglan LiuLei Cao
Nov 29, 2014·Science·Jennifer A Doudna, Emmanuelle Charpentier
Jan 1, 2015·PloS One·Silke Uhrig-SchmidtSebastian Kreuz
Feb 19, 2015·Nature Biotechnology·Lukas E DowScott W Lowe
Dec 19, 2015·International Journal of Pharmaceutical Investigation·Ningning Yang
Feb 10, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Wei HuangLei Cao
Feb 16, 2016·Cell Metabolism·Katrin J SvenssonBruce M Spiegelman
May 4, 2016·Proceedings of the National Academy of Sciences of the United States of America·Yuan XueRobert Langer
Mar 1, 2017·Methods in Molecular Biology·Nicolás Gómez-Banoy, James C Lo
Apr 17, 2017·Molecular Therapy : the Journal of the American Society of Gene Therapy·Pieter R Cullis, Michael J Hope

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.